MT
Healthcare & Life Sciences
Myrobalan Therapeutics
United Statesmyrotx.com/
Myrobalan Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Myrobalan Therapeutics
Based in the United States, Myrobalan Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Myrobalan Therapeutics develops oral small molecule therapies targeting neuroinflammation and demyelination to treat central nervous system diseases such as multiple sclerosis, Alzheimer's, ALS, and Parkinson's disease.
Explore Myrobalan Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.